# SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial

> **NCT04217304** · PHASE2 · TERMINATED · sponsor: **University of Alberta** · enrollment: 41 (actual)

## Conditions studied

- ST Elevation Myocardial Infarction

## Interventions

- **DRUG:** Definity® with High Mechanical Index Ultrasound

## Key facts

- **NCT ID:** NCT04217304
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-02-23
- **Primary completion:** 2026-01-19
- **Final completion:** 2026-01-19
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Unlikely to demonstrate the intended benefit within the planned study design and statistical framework.
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04217304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04217304, "SONOthrombolysis in Patients With an ST-segment Elevation Myocardial Infarction With fibrinoLYSIS (SONOSTEMI-LYSIS) Trial". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04217304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*